Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Statins in Ovarian Cancer
NCT06468254Phase 2Recruiting
- Sponsor
- Anhui Provincial Tumor Hospital
- Start
- Jun 2024
- Primary completion
- May 2025
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in ovarian cancer (2 arms), sponsored by Anhui Provincial Tumor Hospital. Primary endpoints: Progression free survival at 12 months and Disease free survival at 12 months. Started Jun 2024; status: recruiting.
02
Conditions
ovarian cancer
Beyond the preview
Go deeper on NCT06468254.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06468254.